Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/interleukin-8RB

Blood

Volumn 93, Issue 9, 1999, Pages 2791-2797

  Nilsson, Gunnar ^a   Mikovits, Judy A ^b   Metcalfe, Dean D ^b   Taub, Dennis D ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8;

ARTICLE; BINDING AFFINITY; CALCIUM MOBILIZATION; CELL MIGRATION; CHEMOTAXIS; EFFECTOR CELL; FLOW CYTOMETRY; GROWTH REGULATION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; KILLER CELL; MAST CELL; MEMBRANE BINDING; PRIORITY JOURNAL;

EID: 0033135737     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.9.2791.409k27_2791_2797     Document Type: Article

References (34)

1. Galli SJ: The mast cell: A versatile effector cell for a challenging world. Int Arch Allergy Immunol 113:14, 1997
2. Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev 77:1033, 1997
3. Nilsson G, Costa JJ, Metcalfe DD: Mast cells and basophils, in Gallin JI, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. Philadelphia, PA, Lippincott-Raven (in press)
4. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR: The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 79:958, 1992
5. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A: Stem cell factor is a chemotactic factor for human mast cells. J Immunol 153:3717, 1994
6. Gruber BL, Marchese MJ, Kew RR: Transforming growth factor-beta 1 mediates mast cell chemotaxis. J Immunol 152:5860, 1994
7. Nilsson G, Johnell M, Hammer CH, Tiffany HL, Nilsson K, Metcalfe DD, Siegbahn A, Murphy PM: C3a and C5a are chemotaxins for mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157:1693, 1996
8. Hartmann K, Henz BM, Krüger-Krasagakes S, Kohl J, Burger R, Guhl S, Haase I, Lippert U, Zuberbier T: C3a and C5a stimulate chemotaxis of human mast cells. Blood 89:2863, 1997
9. Taub DD: Chemokine-leukocyte interactions. Cytokine Growth Factor Rev 7:355, 1996
10. Rollins BJ: Chemokines. Blood 90:909, 1997
11. Walz A, Peveri P, Aschauer H, Baggiolini M: Purification and amino acid sequencing of NAF, a novel neutrophil activating factor produced by monocytes. Biochem Biophys Res Commun 149:755, 1987
12. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Apella E, Oppenheim JJ, Leonard EJ: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84:9233, 1987
13. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 55:97, 1994
14. Murphy PM: The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12:593, 1994
15. Holmes WE, Lee J, Kuang W-J, Rice GC, Wood WI: Structure and functional expression of a human interleukin-8 receptor. Science 253:1278, 1991
16. Murphy PM, Tiffany HL: Cloning of complementary DNA encoding a functional interleukin-8 receptor. Science 253:1280, 1991
17. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI: Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 267:16283, 1992
18. Moser B, Schumacher C, von Tschamer V, Clark-Lewis I, Baggiolini M: Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J Biol Chem 266:10666, 1991
19. Ceretti DP, Kozlosky CJ, Vanden Bos T, Nelson N, Gearing DP, Beckmann MP: Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2. Mol Immunol 30:359, 1993
20. Ahuja SK, Murphy PM: The CXC chemokines growth-regulated oncogene (GRO) alpha, GRO beta, GRO gamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271:20545, 1996
21. Xu L, Kelvin DJ, Taub DD, Ben-Baruch A, Oppenheim JJ, Wang JM: Modulation of IL-8 receptor expression on purified human T lymphocyte is associated with changed chemotactic responses to IL-8. J Leukoc Biol 57:335, 1995
22. Morohashi H, Miyawaki T, Nomura H, Kuno K, Murakami S, Matsushima K, Mukaida N: Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J Leukoc Biol 57:180, 1995
23. Bacon KB, Flores-Romo L, Life PF, Taub DD, Premack BA, Arkinstall SJ, Wells TN, Schall TJ, Power CA: IL-8-induced signal transduction in T lymphocytes involves receptor-mediated activation of phospholipases C and D. J Immunol 154:3654, 1995
24. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12:345, 1988
25. Nilsson G, Blom T, Kusche GM, Kjellén L, Butterfield JH, Sundström C, Nilsson K, Hellman L: Phenotypic characterization of the human mast cell line HMC-1. Scand J Immunol 39:489, 1994
26. Nilsson G, Blom T, Harvima I, Kusche-Gullberg M, Nilsson K, Hellman L: Stem cell factor-dependent human cord blood derived mast cells express α- and β-tryptase, heparin and chondroitin sulphate. Immunology 88:308, 1996
27. Taub DD, Key ML, Clark D, Turcovski-Corrales SM: Chemotaxis of T lymphocytes on extracellular matrix proteins. Analysis of the in vitro method to quantitate chemotaxis of human T cells. J Immunol Methods 184:187, 1995
28. Zigmond SH, Hirsch JG: Leukocyte locomotion and chemotaxis. J Exp Med 137:387, 1973
29. Rot A: Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism. Eur J Immunol 23:303, 1993
30. Thelen M, Peveri P, Kernen P, von Tscharner V, Walz A, Baggiolini M: Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist. FASEB J 2:2702, 1988
31. Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Appella E, Kung HF, Leonard EJ, Oppenheim JJ: Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 167:1883, 1988
32. Fokkens WJ, Godthelp T, Holm AF, Blom H, Mulder PG, Vroom TM, Rijntjes E: Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allergic controls: A biopsy study. Clin Exp Allergy 22:701, 1992
33. Mattoli S, Ackerman V, Vittori E, Marini M: Mast cell chemotactic activity of RANTES. Biochem Biophys Res Commun 209:316, 1995
34. Luster AD: Mechanisms of disease: Chemokines - Chemotactic cytokines that mediate inflammation. N Engl J Med 338:436, 1998